comparemela.com

Latest Breaking News On - Blenrep - Page 1 : comparemela.com

Blenrep Combo for Relapsed, Refractory Myeloma Improves Outcomes

Patients with relapsed or refractory multiple myeloma had lower progressive disease outcomes when receiving Blenrep with Velcade and dexamethasone, research found.

GSK Drug Pulled From Market Beats J&J Multiple Myeloma Med in Phase 3 Test

GSK took Blenrep off the market last year after the multiple myeloma drug failed its confirmatory study. But GSK now says it has interim data showing Blenrep beat a blockbuster Johnson & Johnson drug in a head-to-head Phase 3 study testing it as an earlier line of therapy.

vimarsana © 2020. All Rights Reserved.